4//SEC Filing
Groenewald Ferdinand 4
Accession 0000950170-25-110531
CIK 0001107421other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:54 PM ET
Size
7.1 KB
Accession
0000950170-25-110531
Insider Transaction Report
Form 4
Groenewald Ferdinand
Vice President of Finance
Transactions
- Award
Common Stock
2025-08-18+10,775→ 10,775 total - Award
Employee Stock Option (right to buy)
2025-08-18+4,000→ 4,000 totalExercise: $2.32Exp: 2035-08-17→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001734018
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 7:54 PM ET
- Size
- 7.1 KB